BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Nuvilex 

1971 Old Cuthbert Road

Cherry Hill  New Jersey  08034  U.S.A.
Phone: 856-433-6088 Fax: 856-354-1077


SEARCH JOBS




Industry
Biotechnology






 Company News
Nuvilex (NVLX) Contracts With University Of Veterinary Medicine In Vienna To Conduct Preclinical Studies On The Use Of Cell-In-A Box® To Develop Diabetes Treatment 10/20/2014 7:30:52 AM
Nuvilex (NVLX) Secures Worldwide License For Insulin-Producing Cells From University of Technology Sydney, For Use In Developing Diabetes Treatment 10/16/2014 7:49:40 AM
Nuvilex (NVLX) Applies To FDA For Orphan Drug Designation For Its Cell-In-A-Box® Treatment For Pancreatic Cancer 10/13/2014 8:20:43 AM
Nuvilex (NVLX) Announces Strategic Changes To Leadership Team And Appoints Prof. Dr. Walter H. Gunzburg As Chief Scientific Officer 10/1/2014 10:10:57 AM
Nuvilex (NVLX)'s Partner, Austrianova, Publishes Scientific Review Article Emphasizing Use Of Cell-In-A-Box® For Treatment Of Diabetes 9/22/2014 8:06:20 AM
Nuvilex (NVLX) Updates Shareholders On Recent Activities And Discusses Future Plans For Development Of Treatments For Cancer And Diabetes 9/18/2014 11:29:48 AM
Nuvilex (NVLX)'s Partner, Austrianova, Receives Prestigious Emerging Enterprises 2014 Best Innovation Award In Singapore 9/8/2014 7:28:11 AM
Nuvilex (NVLX) Submits Application For Orphan Drug Designation To The European Medicines Agency For Its Cell-In-A-Box® Treatment For Pancreatic Cancer 9/2/2014 10:41:03 AM
Nuvilex (NVLX) Begins Preclinical Studies With Translational Drug Development To Determine If Nuvilex's Unique Cancer Treatment Can Slow Accumulation Of Malignant Ascites Fluid 8/20/2014 7:36:40 AM
Nuvilex (NVLX) Announces Publication Of Combined Results Of The Initial Phase 1/2 Clinical Trial And A Second Phase 2 Clinical Trial Of The Cell-In-A-Box® Plus Ifosfamide Combination In Patients With Advanced, Inoperable Pancreatic Cancer 8/14/2014 7:45:24 AM
12345678910...